Adherence to highly active antiretroviral therapy (HAART): a meta-analysis (Q45889695)

17 December 2017

meta-analysis

0 references

title

Adherence to highly active antiretroviral therapy (HAART): a meta-analysis (English)

1 reference

17 December 2017

author name string

Carmen Ortego

1

1 reference

17 December 2017

Tania B Huedo-Medina

2

1 reference

17 December 2017

Javier Llorca

3

1 reference

17 December 2017

Lourdes Sevilla

4

1 reference

17 December 2017

Pilar Santos

5

1 reference

17 December 2017

Elías Rodríguez

6

1 reference

17 December 2017

Michelle R Warren

7

1 reference

17 December 2017

Javier Vejo

8

1 reference

17 December 2017

publication date

1 October 2011

1 reference

17 December 2017

published in

AIDS and Behavior

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

page(s)

1381-1396

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s10461-011-9942-x

exact match

0 references

cites work

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Patient adherence to HIV medication regimens: a review of published and abstract reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Practical and conceptual challenges in measuring antiretroviral adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to HAART Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Estimating Effect Size Under Publication Bias: Small Sample Properties and Robustness of a Random Effects Selection Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Patients' Answers to Simple Questions About Treatment Satisfaction and Adherence and Depression Are Associated with Failure of HAART: A Cross-Sectional Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Assessing relationships between health-related quality of life and adherence to antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Factors affecting patient adherence to highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

The impact of illicit drug use and substance abuse treatment on adherence to HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to HAART among HIV-infected persons in rural Louisiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Factors influencing adherence to highly active antiretroviral therapy in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

An analysis fo causes for the discontinuation of a simplified antiretroviral regimen with abacavir, lamivudine and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Personality, quality of life and HAART adherence among men and women living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Monitoring adherence to HIV therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Estudio longitudinal de adherencia, satisfacción y efectividad del tratamiento antirretroviral administrado una vez al día, frente a dos veces al día, en una cohorte española de infectados por el VIH (estudio CUVA: cualquiera una vez al día)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Adherence is not a barrier to successful antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Morphologic Alterations in HIV-Infected People with Lipodystrophy Are Associated with Good Adherence to HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

Reacciones adversas del tratamiento antirretroviral: relación entre los síntomas percibidos y el cumplimiento terapéutico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-011-9942-X

10.1007/S10461-011-9942-X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017